Product Details
Enerzair Breezhaler
Indacaterol Acetate + Glycopyrronium Bromide + Mometasone Furoate150 mcg + 50 mcg + 160 mcg
Powder for Inhalation
Capsule
DIN/PIN/NPN
02501244
Manufacturer
Novartis Pharma Canada Inc.
Formulary Listing Date
2022-02-28
Unit Price
3.4277
Amount MOH Pays
3.4277
Coverage Status
Limited Use Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
R03AL12
Interchangeable Products
NOLU Clinical Criteria
| LU Code | Auth. Period | Clinical Criteria |
|---|---|---|
| 627 | Indefinite | For the treatment of asthma in adult patients inadequately controlled with a maintenance combination of a long-acting beta-2 agonist (LABA) and a medium or high dose of an inhaled corticosteroid (ICS), who experienced one or more asthma exacerbations in the previous 12 months |